Accretive Health, Inc. 4/A
4/A · Accretive Health, Inc. · Filed Feb 12, 2016
Insider Transaction Report
Form 4/AAmended
Rizk Emad T.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2015-12-31+1,500,000→ 2,520,854 total
Footnotes (1)
- [F1]The amount of securities beneficially owned following the reported transaction as reported in the Reporting Person's original Form 4 did not take into account the reduction for 57,213 shares of restricted common stock that were used to satisfy tax withholding obligations as a result of the vesting of the restricted common stock held by the Reporting Person since July 10, 2015.